SGAM
Smith Group Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $562K | Sell |
19,012
-73
| -0.4% | -$2.16K | 0.04% | 122 |
|
|
2025
Q1 | $570K | Buy |
19,085
+73
| +0.4% | +$2.18K | 0.04% | 123 |
|
|
2024
Q4 | $545K | Buy |
19,012
+188
| +1% | +$5.39K | 0.04% | 136 |
|
|
2024
Q3 | $727K | Buy |
18,824
+3,774
| +25% | +$146K | 0.06% | 76 |
|
|
2024
Q2 | $485K | Buy |
15,050
+90
| +0.6% | +$2.9K | 0.04% | 84 |
|
|
2024
Q1 | $581K | Hold |
14,960
| – | – | 0.03% | 129 |
|
|
2023
Q4 | $460K | Buy |
+14,960
| New | +$460K | 0.03% | 133 |
|
|
2022
Q1 | $241K | Sell |
11,815
-8,487
| -42% | -$173K | 0.01% | 157 |
|
|
2021
Q4 | $379K | Sell |
20,302
-524
| -3% | -$9.78K | 0.02% | 153 |
|
|
2021
Q3 | $411K | Sell |
20,826
-334
| -2% | -$6.59K | 0.02% | 144 |
|
|
2021
Q2 | $500K | Sell |
21,160
-205
| -1% | -$4.84K | 0.02% | 135 |
|
|
2021
Q1 | $506K | Hold |
21,365
| – | – | 0.03% | 131 |
|
|
2020
Q4 | $428K | Sell |
21,365
-6,970
| -25% | -$140K | 0.02% | 145 |
|
|
2020
Q3 | $590K | Sell |
28,335
-3,420
| -11% | -$71.2K | 0.03% | 121 |
|
|
2020
Q2 | $556K | Sell |
31,755
-19,758
| -38% | -$346K | 0.03% | 127 |
|
|
2020
Q1 | $841K | Buy |
51,513
+35,883
| +230% | +$586K | 0.05% | 98 |
|
|
2019
Q4 | $322K | Hold |
15,630
| – | – | 0.01% | 164 |
|
|
2019
Q3 | $179K | Buy |
+15,630
| New | +$179K | 0.01% | 198 |
|